BIONEXT – Trademark Portfolio
Entity Type: 98
BIONEXT holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 6 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BIOTFUEL.
4 rue Boussingault
F-67000 STRASBOURG
Showing of trademarks Trademarks
Trademark Classifications
BIONEXT's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Frequently Asked Questions
How many trademarks does BIONEXT have?
BIONEXT has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered.
What trademark classes does BIONEXT file in?
BIONEXT files trademarks across 6 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 11 (Environmental Control), Class 4 (Lubricants & Fuels). Class 42 covers scientific and technological services; industrial analysis and research services.
What are BIONEXT's most well-known trademarks?
BIONEXT's registered trademark portfolio includes well-known marks such as BIOTFUEL. These are among 1 currently registered trademark in the portfolio.
What is BIONEXT's trademark registration success rate?
BIONEXT has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.